SLC3A2 and breast carcinoma: Upregulation of xCT subunits, solute carrier family 7 number 11 (SLCA11) or solute carrier family 3 member 2 (SLC3A2), increased the GPX4 expression, but paradoxically hypersensitized breast cancer cells to erastin or RSL3-induced ferroptosis (108).